Giraffe Bio Uses Biotech to Boost Copper Recovery Amid Global Shortage
Global demand for copper is expected to outstrip supply by up to 25% by 2040 due to the AI data center boom and widespread electrification. Traditional mining methods are costly and inefficient, prompting a new wave of biotechnology startups aiming to enhance mineral extraction from existing mines. Giraffe Bio has developed bespoke biomolecules that can increase copper recovery rates by up to 5%, significantly improving mine output. The startup recently raised $6.4 million in seed funding led by Orion Industrial Ventures, with participation from BHP Ventures and other investors. Unlike competitors using microbes directly for extraction, Giraffe grows engineered microbes in bioreactors to produce targeted compounds that integrate into existing mining processes without the complexities of maintaining live organisms. Giraffe Bio’s technology is currently focused on copper but can be adapted to extract gold or silver as well. The company also aims to replace harmful chemicals used in flotation and depression processes with environmentally friendly biomolecules, reducing environmental impact while maximizing mineral recovery.
Tickers: $BHP
Topics: biotechnology copper resource_extraction startup_funding